In patients with chronic HF, subsequent measurements of BNP or NT-proBNP levels provide independent information about the risk of disease progression, which involves a series of adverse consequences, including ventricular remodeling, malignant ventricular arrhythmia, HF-related hospitalization, transplantation need, and death (81). This evidence concerns the gene NPPB and hydrops fetalis.